Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
AGNC Investment
AGNC
$10.7B
| $4.74M | ﹤0.01% |
515,249
+178,756
| +53% | +$1.64M |
|
2027
Pediatrix Medical
MD
$1.44B
| $4.73M | ﹤0.01% |
329,793
+248,049
| +303% | +$3.56M |
|
2028
Root
ROOT
$1.55B
| $4.73M | ﹤0.01% |
36,977
+24,075
| +187% | +$3.08M |
|
2029
Freshpet
FRPT
$2.56B
| $4.73M | ﹤0.01% |
69,619
-99,816
| -59% | -$6.78M |
|
2030
John B. Sanfilippo & Son
JBSS
$737M
| $4.7M | ﹤0.01% |
74,278
+42,980
| +137% | +$2.72M |
|
2031
Western Alliance Bancorporation
WAL
$9.83B
| $4.69M | ﹤0.01% |
60,171
+57,177
| +1,910% | +$4.46M |
|
2032
Materion
MTRN
$2.37B
| $4.69M | ﹤0.01% |
59,103
-30,109
| -34% | -$2.39M |
|
2033
Domo
DOMO
$714M
| $4.68M | ﹤0.01% |
335,141
+252,274
| +304% | +$3.52M |
|
|
VCIC
2034
Vine Hill Capital Investment Corp. Class A Ordinary Shares
VCIC
$309M
| $4.68M | ﹤0.01% |
450,000
| – | – |
|
2035
Inter&Co
INTR
$3.94B
| $4.67M | ﹤0.01% |
629,080
-1,483,981
| -70% | -$11M |
|
2036
Fastly
FSLY
$1.29B
| $4.66M | ﹤0.01% |
660,496
+574,744
| +670% | +$4.06M |
|
2037
Prospect Capital
PSEC
$1.27B
| $4.66M | ﹤0.01% |
1,465,675
+1,346,273
| +1,128% | +$4.28M |
|
2038
HealthStream
HSTM
$860M
| $4.63M | ﹤0.01% |
167,482
+92,848
| +124% | +$2.57M |
|
2039
Plains GP Holdings
PAGP
$3.68B
| $4.63M | ﹤0.01% |
238,359
+97,758
| +70% | +$1.9M |
|
2040
Surmodics
SRDX
$463M
| $4.62M | ﹤0.01% |
155,618
-50,869
| -25% | -$1.51M |
|
2041
Neurogene
NGNE
$249M
| $4.6M | ﹤0.01% |
307,805
+149,868
| +95% | +$2.24M |
|
2042
CACI
CACI
$10.9B
| $4.6M | ﹤0.01% |
9,644
-36,802
| -79% | -$17.5M |
|
|
AACIU
2043
Armada Acquisition Corp. II Units
AACIU
| $4.59M | ﹤0.01% |
+450,000
| New | +$4.59M |
|
|
ETHM
2044
Dynamix Corporation Class A Ordinary Shares
ETHM
$241M
| $4.59M | ﹤0.01% |
450,000
+300,000
| +200% | +$3.06M |
|
2045
Arteris
AIP
$381M
| $4.58M | ﹤0.01% |
480,515
+199,778
| +71% | +$1.9M |
|
2046
Stepan Co
SCL
$1.1B
| $4.55M | ﹤0.01% |
83,389
+46,935
| +129% | +$2.56M |
|
2047
W.R. Berkley
WRB
$27.6B
| $4.54M | ﹤0.01% |
61,834
-87,983
| -59% | -$6.46M |
|
2048
Red Rock Resorts
RRR
$3.63B
| $4.54M | ﹤0.01% |
87,274
-342,876
| -80% | -$17.8M |
|
2049
Lindblad Expeditions
LIND
$715M
| $4.53M | ﹤0.01% |
387,868
+9,609
| +3% | +$112K |
|
2050
AnaptysBio
ANAB
$564M
| $4.52M | ﹤0.01% |
203,542
+185,735
| +1,043% | +$4.12M |
|